Dysplastic versus proliferative CMML - A retrospective analysis of 91 patients from a single institution

Leukemia Research

Volumn 25, Issue 9, 2001, Pages 741-747

  Nösslinger, Thomas ^a   Reisner, Regina ^a   Grüner, Helga ^a   Tüchler, Heinz ^a   Nowotny, Hadwiga ^a   Pittermann, Elisabeth ^a   Pfeilstöcker, Michael ^a  

^a HANUSCH HOSPITAL   (Austria)

Author keywords

Chronic myelomonocytic leukemia; Myelodysplastic syndromes; Myeloproliferative disorders; Prognosis; Scoring systems

Indexed keywords

ADULT; AGED; ARTICLE; BONE MARROW; BONE MARROW CELL; CANCER CLASSIFICATION; CHRONIC MYELOMONOCYTIC LEUKEMIA; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; EVALUATION; FEMALE; HEMATOLOGY; HUMAN; LABORATORY TEST; LACTATE DEHYDROGENASE BLOOD LEVEL; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; PRELEUKEMIA; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SCORING SYSTEM; SURVIVAL; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA;

AGED; AGED, 80 AND OVER; DISEASE PROGRESSION; FEMALE; HUMANS; LEUKEMIA, MYELOMONOCYTIC, CHRONIC; MALE; MIDDLE AGED; MYELOPROLIFERATIVE DISORDERS; NEURAL TUBE DEFECTS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 0034898906     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(01)00014-5     Document Type: Article

References (25)

1. Proposals for the classification of the myelodysplastic syndromes
2. FAB classification of myelodysplastic syndromes: Merits and controversies
3. The chronic myeloid leukemias: Guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukemia. Proposals by the FAB cooperative leukaemia group
4. Chronic myelomonocytic leukemia (CMML). A myelodysplastic or myeloproliferative syndrome?
5. Chronic myelomonocytic leukemia
6. Prognostic factors in adult chronic myelomonocytic leukemia: An analysis of 107 cases
7. Chronic myelomonocytic leukemia according to FAB classification: Analysis of 35 cases
8. World Health Organization of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the clinical advisory committee meeting-airlie house, virginia, november 1997
9. Counterstained enhanced chromosome binding
10. Myelodysplastic syndromes: A scoring system with prognostic significance
11. Prognostic features of chronic myelomonocytic leukemia: A modified Bournemouth score gives the best prediction of survival
12. Primary myelodysplastic syndromes: Analysis of prognostic factors in 235 patients and proposals for an improved scoring system
13. Cytogenetic analysis has strong prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: A report on 408 cases
14. International scoring system for evaluating prognosis in myelodysplastic syndromes
15. Non parametric estimation from incomplete observations
16. Regression models and life tables
17. Cross-validation of prognostic scores in myelodysplastic syndromes on 386 patients from a single institution confirms importance of cytogenetics
18. Problems in the classification of CMML-dysplastic versus proliferative type
19. Myelodysplasia - Review article
20. Topotecan, a topoisomerase I inhibitor, is active in the treatment of myelodysplastic syndrome and chronic myelomonocytic leukemia
21. Antithymocyte globulin for patients with myelodysplastic syndrome
22. Cyclosporin A therapy in hypoplastic MDS patients and certain refractory anaemias without hypoplastic bone marrow
23. Continuous infusion of low-dose 5-Aza-2′-deoxycytidine in elderly patients with high risk myelodysplastic syndrome
24. Interleukin 10 inhibits growth and granulocyte/macrophage colony-stimulating factor production in chronic myelomonocytic leukemia cells